Recent searches
Search options
Administered by:
This review gives insight into recent and developing approaches to the management of esophageal cancer, a malignancy that is especially difficult to treat. The authors indicate that the advent of immune-checkpoint inhibitors, which harness and enhance the host immune response against cancer, has substantially improved survival in squamous cell carcinoma, although less so for adenocarcinoma.
https://www.esocan.org/advances-in-management-of-esophageal-cancer/
#cancer #esophageal #cancerTreatment
ESOCAN NewsAdvances in management of esophageal cancerWhile the ESOCAN website and blog focus on the epidemiology and prevention of esophageal cancer, this review gives insight into recent and developing approaches to the management of esophageal squamous cell and adenocarcinoma. Key points that the authors highlight include:
• With advances in molecular profiling technologies, the diferential
mechanistic underpinnings